By acting on receptors in the pancreas, it boosts insulin production, which helps manage blood sugar levels, particularly beneficial for people with type 2 diabetes struggling with obesity
This post has been sponsored by the PRIMP Network
The efficacy and safety of the naltrexone/bupropion combination for the treatment of obesity: an update NB32 (32 mg naltrexone and 360 mg bupropion prolonged release) is FDA- and EMA-approved as an adjunct to lifestyle interventions for weight loss, showing 5.0%-9.3% total weight loss (3.2%-5.2% vs
Semaglutide (subcutaneous) and influenza vaccine (intramuscular) should be administered at different anatomical sites, preferably different limbs, if given on the same day
Research suggests this ceiling sits somewhere between 25g and 40g depending on body size and activity level
For extended-release capsules, you can open them and sprinkle the contents onto a spoonful of applesauce if you have trouble swallowing capsules